{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:56:11Z","timestamp":1790571371603,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to externally validate a logistic strategy for predicting the integrated molecular diagnosis of glioblastoma (mGBM) as defined by the World Health Organization (WHO) 2021 Classification of Tumors of the Central Nervous System (CNS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ethical approval was obtained for a retrospective study of diffuse gliomas (CNS WHO grades 2\u20134) with available isocitrate dehydrogenase (IDH) and 1p19q status and whole genome profiling for mGBM, where appropriate. Age and MRI characteristics (apparent diffusion coefficient (ADC), tumor location, contrast enhancement pattern, cyst(s), and calcification) were scored by two observers blinded to the tissue results and to each other\u2019s results. Observer concordance was assessed using intraclass correlation coefficient (ICC) and Cohen\u2019s kappa. Diagnostic performance, comparisons using McNemar and DeLong tests, and model calibration were obtained in SPSS 27 and Python (v3.12).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 108 consecutively enrolled cases were eligible from January to December 2023 (mean age 56.9 \u00b1 15.5 years; range 20\u201382), comprising 85 mGBM\/IDH wild-type (IDH\n                      <jats:sup>wt<\/jats:sup>\n                      ) and 23 IDH mutant (IDH\n                      <jats:sup>mut<\/jats:sup>\n                      ) gliomas. Model sensitivity ranged from 97% to 99%, with 48%\u201391% specificity, 87%\u201397% accuracy, and AUCs of 0.93\u20130.98. For the trainee, model use produced increases in sensitivity from 87.1% to 97.6% with model A and 96.5% with model B and in accuracy from 84.3% to 87.0% and 91.7%, respectively. No within-observer difference in overall accuracy and no paired AUC comparison remained statistically significant after Holm adjustment. Model B demonstrated more consistent calibration across observers. Among eight mGBM lacking rim enhancement, correct classification by the trainee increased numerically from 12.5% to 100% with model A and 87.5% with model B.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The logistic strategy achieved high sensitivity and discrimination for identifying mGBM according to CNS WHO 2021. Model use produced increases in trainee performance, particularly sensitivity, while Model B demonstrated more consistent calibration across observers. These findings support the further evaluation of the tool, particularly in radiologically atypical mGBM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1884886","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:28:44Z","timestamp":1790569724000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A logistic paradigm to predict molecular glioblastoma on clinical MRI"],"prefix":"10.3389","volume":"16","author":[{"given":"Yousif","family":"Aldabbagh","sequence":"first","affiliation":[{"name":"Precision Imaging, School of Medicine, University of Nottingham","place":["Nottingham, United Kingdom"]},{"name":"Radiology Department, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem","family":"Bhatti","sequence":"additional","affiliation":[{"name":"Precision Imaging, School of Medicine, University of Nottingham","place":["Nottingham, United Kingdom"]},{"name":"Radiology Department, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Menon","sequence":"additional","affiliation":[{"name":"Radiology Department, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Precision Imaging, School of Medicine, University of Nottingham","place":["Nottingham, United Kingdom"]},{"name":"Nottingham NIHRBiomedical Research Centre","place":["Nottingham, United Kingdom"]},{"name":"Medical Physics & Clinical Engineering, Nottingham University Hospitals","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Smits","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Erasmus University Medical Center (Erasmus MC)","place":["Rotterdam, Netherlands"]},{"name":"Medical Delta","place":["Delft, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Maynard","sequence":"additional","affiliation":[{"name":"Imaging Department, Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Paine","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goldspring","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nottingham University Hospitals","place":["Nottingham, United Kingdom"]},{"name":"Children\u2019s Brain Tumor Research Centre, University of Nottingham","place":["Nottingham, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie C.","family":"Thust","sequence":"additional","affiliation":[{"name":"Precision Imaging, School of Medicine, University of Nottingham","place":["Nottingham, United Kingdom"]},{"name":"Radiology Department, Nottingham University Hospitals NHS Trust","place":["Nottingham, United Kingdom"]},{"name":"Nottingham NIHRBiomedical Research Centre","place":["Nottingham, United Kingdom"]},{"name":"Department of Translational Neuroscience and Stroke, UCL Institute of Neurology","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20142020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro-Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Eckel-Passow","year":"2015","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402121","article-title":"Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas","volume":"372","author":"Brat","year":"2015","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1913-0","article-title":"cIMPACT-NOW update 3: recommended diagnostic criteria for \u201cDiffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV","volume":"136","author":"Brat","year":"2018","journal-title":"Acta Neuropathol (Berl)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ccell.2019.02.007","article-title":"Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis","volume":"35","author":"K\u00f6rber","year":"2019","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac089","article-title":"Prospective genomically guided identification of \u201cearly\/evolving\u201d and \u201cundersampled\u201d IDH-wildtype glioblastoma leads to improved clinical outcomes","volume":"24","author":"Zhang","year":"2022","journal-title":"Neuro-Oncol"},{"key":"B8","article-title":"BNOS guideline for tissue sampling of brain tumours: Addressing insufficient material submitted for diagnosis, genetics and emerging novel therapies","author":"Kurian","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s003300050173","article-title":"Supratentorial diffuse astrocytic tumours: proposal of an MRI classification","volume":"7","author":"Pierallini","year":"1997","journal-title":"Eur Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-020-02532-7","article-title":"Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review","volume":"63","author":"Lasocki","year":"2021","journal-title":"Neuroradiology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6965","article-title":"Regional and volumetric parameters for diffusion-weighted WHO grade II and III glioma genotyping: a method comparison","volume":"42","author":"Thust","year":"2021","journal-title":"Am J Neuroradiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaf103","article-title":"Apparent diffusion coefficient for genetic characterisation of untreated adult gliomas: a meta-analysis stratified by methods","volume":"7","author":"Bhatti","year":"2025","journal-title":"Neuro-Oncol Adv"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108579","article-title":"Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas","volume":"246","author":"Zang","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-02975-0","article-title":"Conventional MRI features can predict the molecular subtype of adult grade 2\u20133 intracranial diffuse gliomas","volume":"64","author":"Lasocki","year":"2022","journal-title":"Neuroradiology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020191832","article-title":"World Health Organization grade II\/III glioma molecular status: prediction by MRI morphologic features and apparent diffusion coefficient","volume":"296","author":"Maynard","year":"2020","journal-title":"Radiology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp19X701861","article-title":"Missed opportunities for diagnosing brain tumours in primary care: a qualitative study of patient experiences","volume":"69","author":"Walter","year":"2019","journal-title":"Br J Gen Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233120","article-title":"MRI scoring systems for predicting isocitrate dehydrogenase mutation and chromosome 1p\/19q codeletion in adult-type diffuse glioma lacking contrast enhancement","volume":"311","author":"Kang","year":"2024","journal-title":"Radiology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-018-5314-5","article-title":"Glioma imaging in Europe: a survey of 220 centres and recommendations for best clinical practice","volume":"28","author":"Thust","year":"2018","journal-title":"Eur Radiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-02937-6","article-title":"Reproducibility of volume analysis of dynamic susceptibility contrast perfusion-weighted imaging in untreated glioblastomas","volume":"64","author":"Roques","year":"2022","journal-title":"Neuroradiology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac166","article-title":"Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning","volume":"25","author":"van der Voort","year":"2023","journal-title":"Neuro-Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1409760","article-title":"Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis","volume":"14","author":"Chen","year":"2024","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3174\/ajnr.A6875","article-title":"Noninvasive determination of IDH and 1p19q status of lower-grade gliomas using MRI radiomics: a systematic review","volume":"42","author":"Bhandari","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.220058","article-title":"The University of California San Francisco preoperative diffuse glioma MRI dataset","volume":"4","author":"Calabrese","year":"2022","journal-title":"Radiol Artif Intell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-10405-9","article-title":"Intratumoral calcification: not only a diagnostic but also a prognostic indicator in oligodendrogliomas","volume":"34","author":"Zhu","year":"2024","journal-title":"Eur Radiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.03.003","article-title":"Modelling MR and clinical features in grade II\/III astrocytomas to predict IDH mutation status","volume":"114","author":"Hyare","year":"2019","journal-title":"Eur J Radiol"},{"key":"B28","unstructured":"Vasari Research Project. Cancer Imaging Arch. Tcia Public Access\n          \n          2020"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-018-0981-x","article-title":"Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas","volume":"42","author":"Kanazawa","year":"2019","journal-title":"Neurosurg Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8776","article-title":"Automated diffusion analysis for non-invasive prediction of IDH genotype in WHO grade 2-3 gliomas","volume":"46","author":"Wu","year":"2025","journal-title":"Am J Neuroradiol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1884886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:28:45Z","timestamp":1790569725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1884886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":30,"alternative-id":["10.3389\/fonc.2026.1884886"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1884886","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1884886"}}